Mitochondrial functions in astrocytes: Neuroprotective implications from oxidative damage by rotenone

Neuroscience Research

Volumn 74, Issue 2, 2012, Pages 80-90

  Cabezas, Ricardo ^a   El Bachá, Ramon Santos ^b   González, Janneth ^a   Barreto, George E ^a  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Astrocytes; Mitochondria; Neuroprotection; Oxidative stress; Rotenone

Indexed keywords

CHAPERONE; GLUTATHIONE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR BB; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SUPEROXIDE DISMUTASE;

APOPTOSIS; ASTROCYTE; BRAIN DAMAGE; BRAIN DEVELOPMENT; BRAIN MITOCHONDRION; CALCIUM CELL LEVEL; CELL ENERGY; CELL PROTECTION; CELL SURVIVAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

AGRICULTURAL WORKERS' DISEASES; ANIMALS; APOPTOSIS; ASTROCYTES; BRAIN; CHAPERONINS; ELECTRON TRANSPORT; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID PEROXIDATION; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NF-KAPPA B; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; PESTICIDES; ROTENONE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS;

EID: 84868691367     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2012.07.008     Document Type: Review

References (148)

1. Aberg N.D., Brywe K.G., Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Scient. World J. 2006, 6:53-80.
2. Ahmadi F.A., Grammatopoulos T.N., Poczobutt A.M., Jones S.M., Snell L.D., Das M., Zawada W.M. Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis. Neurochem. Res. 2008, 33:886-901.
3. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
4. Andrae J., Gallini R., Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008, 22:1276-1312.
5. Ascherio A., Chen H., Weisskopf M.G., O'Reilly E., McCullough M.L., Calle E.E., Schwarzschild M.A., Thun M.J. Pesticide exposure and risk for Parkinson's disease. Ann. Neurol. 2006, 60:197-203.
6. Bambrick L., Kristian T., Fiskum G. Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem. Res. 2004, 29:601-608.
7. Barreto G.E., Gonzalez J., Torres Y., Morales L. Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury. Neurosci. Res. 2011, 71:107-113.
8. Bauereis B., Haskins W.E., Lebaron R.G., Renthal R. Proteomic insights into the protective mechanisms of an in vitro oxidative stress model of early stage Parkinson's disease. Neurosci. Lett. 2011, 488:11-16.
9. Bazan N.G., Marcheselli V.L., Cole-Edwards K. Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. N. Y. Acad. Sci. 2005, 1053:137-147.
10. Bender A.S., Woodbury D.M., White H.S. Ionic dependence of adenosine uptake into cultured astrocytes. Brain Res. 1994, 661:1-8.
11. Bender A.S., Woodbury D.M., White H.S. The rapid L- and D-aspartate uptake in cultured astrocytes. Neurochem. Res. 1997, 22:721-726.
12. Bentzer P., Davidsson H., Grande P.O. Microdialysis-based long-term measurements of energy-related metabolites in the rat brain following a fluid percussion trauma. J. Neurotrauma 2000, 17:441-447.
13. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000, 3:1301-1306.
14. Braak H., de Vos R.A., Bohl J., Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 2006, 396:67-72.
15. Brown G.C. Nitric oxide and mitochondria. Front. Biosci. 2007, 12:1024-1033.
16. Bushong E.A., Martone M.E., Jones Y.Z., Ellisman M.H. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J. Neurosci. 2002, 22:183-192.
17. Butterfield D.A., Bader Lange M.L., Sultana R. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease. Biochim. Biophys. Acta 2010, 1801:924-929.
18. Calabrese V., Boyd-Kimball D., Scapagnini G., Butterfield D.A. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes. In vivo 2004, 18:245-267.
19. Cohen B.H. Pharmacologic effects on mitochondrial function. Dev. Disabil. Res. Rev. 2010, 16:189-199.
20. Chan P.H. Role of oxidants in ischemic brain damage. Stroke 1996, 27:1124-1129.
21. Chen Y., Swanson R.A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 2003, 23:137-149.
22. Cherian L., Goodman J.C., Robertson C.S. Brain nitric oxide changes after controlled cortical impact injury in rats. J. Neurophysiol. 2000, 83:2171-2178.
23. Chiarugi A., Moskowitz M.A. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J. Neurochem. 2003, 85:306-317.
24. Davis R.L., Syapin P.J. Ethanol increases nuclear factor-kappa B activity in human astroglial cells. Neurosci. Lett. 2004, 371:128-132.
25. de Oliveira D.M., Barreto G., Galeano P., Romero J.I., Holubiec M.I., Badorrey M.S., Capani F., Alvarez L.D. Paullinia cupana Mart. var. Sorbilis protects human dopaminergic neuroblastoma SH-SY5Y cell line against rotenone-induced cytotoxicity. Hum. Exp. Toxicol. 2011, 30:1382-1391.
26. Dhillon A.S., Tarbutton G.L., Levin J.L., Plotkin G.M., Lowry L.K., Nalbone J.T., Shepherd S. Pesticide/environmental exposures and Parkinson's disease in East Texas. J. Agromedicine 2008, 13:37-48.
27. Di Monte D.A., Tokar I., Langston J.W. Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures. Toxicol. Appl. Pharmacol. 1999, 158:296-302.
28. Diaz-Corrales F.J., Asanuma M., Miyazaki I., Miyoshi K., Ogawa N. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration. Neuroscience 2005, 133:117-135.
29. Dick F.D. Parkinson's disease and pesticide exposures. Br. Med. Bull. 2006, 79-80:219-231.
30. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 2000, 62:649-671.
31. Duffy P., Schmandke A., Sigworth J., Narumiya S., Cafferty W.B., Strittmatter S.M. 2009 Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J. Neurosci. 2009, 29:15266-15276.
32. Dugan L.L., Bruno V.M., Amagasu S.M., Giffard R.G. Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J. Neurosci. 1995, 15:4545-4555.
33. Dugan L.L., Kim-Han J.S. Astrocyte mitochondria in in vitro models of ischemia. J. Bioenerg. Biomembr. 2004, 36:317-321.
34. Duncan A.J., Heales S.J. Nitric oxide and neurological disorders. Mol. Aspects Med. 2005, 26:67-96.
35. Erecinska M., Pleasure D., Nelson D., Nissim I., Yudkoff M. Cerebral aspartate utilization: near-equilibrium relationships in aspartate aminotransferase reaction. J. Neurochem. 1993, 60:1696-1706.
36. Escartin C., Bonvento G. Targeted activation of astrocytes: a potential neuroprotective strategy. Mol. Neurobiol. 2008, 38:231-241.
37. Falk T., Zhang S., Sherman S.J. Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease. Mol. Neurodegener. 2009, 4:49.
38. Fendel U., Tocilescu M.A., Kerscher S., Brandt U. Exploring the inhibitor binding pocket of respiratory complex I. Biochim. Biophys. Acta 2008, 1777:660-665.
39. Fitch M.T., Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 2008, 209:294-301.
40. Forslin Aronsson S., Spulber S., Popescu L.M., Winblad B., Post C., Oprica M., Schultzberg M. alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides 2006, 40:65-75.
41. Gahm C., Holmin S., Wiklund P.N., Brundin L., Mathiesen T. Neuroprotection by selective inhibition of inducible nitric oxide synthase after experimental brain contusion. J. Neurotrauma 2006, 23:1343-1354.
42. Gao X.F., Wang W., Yu Q., Burnstock G., Xiang Z.H., He C. Astroglial P2X7 receptor current density increased following long-term exposure to rotenone. Purinergic Signal 2011, 7:65-72.
43. Giffard R.G., Xu L., Zhao H., Carrico W., Ouyang Y., Qiao Y., Sapolsky R., Steinberg G., Hu B., Yenari M.A. Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J. Exp. Biol. 2004, 207:3213-3220.
44. Giordano G., Kavanagh T.J., Costa L.G. Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE-71. Neurotoxicology 2009, 30:326-329.
45. Goss J.R., Taffe K.M., Kochanek P.M., DeKosky S.T. The antioxidant enzymes glutathione peroxidase and catalase increase following traumatic brain injury in the rat. Exp. Neurol. 1997, 146:291-294.
46. Greenamyre J.T., Betarbet R., Sherer T.B. The rotenone model of Parkinson's disease: genes, environment and mitochondria. Parkinsonism Relat. Disord. 2003, 9(Suppl. 2):S59-S64.
47. Greenamyre J.T., Cannon J.R., Drolet R., Mastroberardino P.G. Lessons from the rotenone model of Parkinson's disease. Trends Pharmacol. Sci. 2010, 31:141-142. (author reply 142-143).
48. Greenamyre J.T., MacKenzie G., Peng T.I., Stephans S.E. Mitochondrial dysfunction in Parkinson's disease. Biochem. Soc. Symp. 1999, 66:85-97.
49. Greenamyre J.T., Sherer T.B., Betarbet R., Panov A.V. Complex I and Parkinson's disease. IUBMB Life 2001, 52:135-141.
50. Greve M.W., Zink B.J. Pathophysiology of traumatic brain injury. Mt Sinai J. Med. 2009, 76:97-104.
51. Guo X., Nakamura K., Kohyama K., Harada C., Behanna H.A., Watterson D.M., Matsumoto Y., Harada T. Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis. Neurosci. Res. 2007, 59:457-466.
52. Gyulkhandanyan A.V., Feeney C.J., Pennefather P.S. Modulation of mitochondrial membrane potential and reactive oxygen species production by copper in astrocytes. J. Neurochem. 2003, 87:448-460.
53. Hamby M.E., Sofroniew M.V. Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 2010, 7:494-506.
54. Hegde M.L., Mantha A.K., Hazra T.K., Bhakat K.K., Mitra S., Szczesny B. Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases. Mech. Ageing Dev. 2012.
55. Hirrlinger J., Dringen R. The cytosolic redox state of astrocytes: maintenance, regulation and functional implications for metabolite trafficking. Brain Res. Rev. 2010, 63:177-188.
56. Hoglinger G.U., Lannuzel A., Khondiker M.E., Michel P.P., Duyckaerts C., Feger J., Champy P., Prigent A., Medja F., Lombes A., Oertel W.H., Ruberg M., Hirsch E.C. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J. Neurochem. 2005, 95:930-939.
57. Hollerhage M., Matusch A., Champy P., Lombes A., Ruberg M., Oertel W.H., Hoglinger G.U. Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies. Exp. Neurol. 2009, 220:133-142.
58. Hortobagyi T., Gorlach C., Benyo Z., Lacza Z., Hortobagyi S., Wahl M., Harkany T. Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: neuroprotection by 3-aminobenzamide. Neuroscience 2003, 121:983-990.
59. Huang J., Philbert M.A. Cellular responses of cultured cerebellar astrocytes to ethacrynic acid-induced perturbation of subcellular glutathione homeostasis. Brain Res. 1996, 711:184-192.
60. Igarashi T., Huang T.T., Noble L.J. Regional vulnerability after traumatic brain injury: gender differences in mice that overexpress human copper, zinc superoxide dismutase. Exp. Neurol. 2001, 172:332-341.
61. Isman M.B. Botanical insecticides, deterrents, and repellents in modern agriculture and an increasingly regulated world. Annu. Rev. Entomol. 2006, 51:45-66.
62. Jarlestedt K., Rousset C.I., Faiz M., Wilhelmsson U., Stahlberg A., Sourkova H., Pekna M., Mallard C., Hagberg H., Pekny M. Attenuation of reactive gliosis does not affect infarct volume in neonatal hypoxic-ischemic brain injury in mice. PLoS One 2010, 5:e10397.
63. Johnson J.A., Johnson D.A., Kraft A.D., Calkins M.J., Jakel R.J., Vargas M.R., Chen P.C. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 2008, 1147:61-69.
64. Kakizuka A. Protein precipitation: a common etiology in neurodegenerative disorders?. Trends Genet. 1998, 14:396-402.
65. Kaltschmidt B., Uherek M., Volk B., Baeuerle P.A., Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:2642-2647.
66. Kang W., Hebert J.M. Signaling pathways in reactive astrocytes, a genetic perspective. Mol. Neurobiol. 2011, 43:147-154.
67. Karimi-Abdolrezaee S., Billakanti R. Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects. Mol. Neurobiol 2012, PMID: 22684804, [Epub ahead of print].
68. Kawasaki A., Hayashi T., Nakachi K., Trosko J.E., Sugihara K., Kotake Y., Ohta S. Modulation of connexin 43 in rotenone-induced model of Parkinson's disease. Neuroscience 2009, 160:61-68.
69. Kimelberg H.K., Nedergaard M. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 2010, 7:338-353.
70. Knott A.B., Bossy-Wetzel E. Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration. Ann. N. Y. Acad. Sci. 2008, 1147:283-292.
71. Kushnareva Y., Murphy A.N., Andreyev A. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem. J. 2002, 368:545-553.
72. Lash L.H., Putt D.A., Hueni S.E., Cao W., Xu F., Kulidjian S.J., Horwitz J.P. Cellular energetics and glutathione status in NRK-52E cells: toxicological implications. Biochem. Pharmacol. 2002, 64:1533-1546.
73. LeDoux S.P., Druzhyna N.M., Hollensworth S.B., Harrison J.F., Wilson G.L. Mitochondrial DNA repair: a critical player in the response of cells of the CNS to genotoxic insults. Neuroscience 2007, 145:1249-1259.
74. Lee J., Giordano S., Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 2012, 441:523-540.
75. Lee S., Williamson J., Lothman E.W., Szele F.G., Chesselet M.F., Von Hagen S., Sapolsky R.M., Mattson M.P., Christakos S. Early induction of mRNA for calbindin-D28k and BDNF but not NT-3 in rat hippocampus after kainic acid treatment. Brain Res. Mol. Brain Res. 1997, 47:183-194.
76. Lewen A., Sugawara T., Gasche Y., Fujimura M., Chan P.H. Oxidative cellular damage and the reduction of APE/Ref-1 expression after experimental traumatic brain injury. Neurobiol. Dis. 2001, 8:380-390.
77. Lindenau J., Noack H., Possel H., Asayama K., Wolf G. Cellular distribution of superoxide dismutases in the rat CNS. Glia 2000, 29:25-34.
78. Liu B., Gao H.M., Hong J.S. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Perspect. 2003, 111:1065-1073.
79. Lluis J.M., Buricchi F., Chiarugi P., Morales A., Fernandez-Checa J.C. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res. 2007, 67:7368-7377.
80. Madhavan L., Ourednik V., Ourednik J. Neural stem/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression. Stem Cells 2008, 26:254-265.
81. Maier C.M., Chan P.H. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 2002, 8:323-334.
82. Mao X., Moerman-Herzog A.M., Wang W., Barger S.W. Differential transcriptional control of the superoxide dismutase-2 kappaB element in neurons and astrocytes. J. Biol. Chem. 2006, 281:35863-35872.
83. Mattson M.P. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 2005, 30:883-893.
84. Mattson M.P. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann. N. Y. Acad. Sci. 2008, 1144:97-112.
85. Meister A. Mitochondrial changes associated with glutathione deficiency. Biochim. Biophys. Acta 1995, 1271:35-42.
86. Mena N.P., Bulteau A.L., Salazar J., Hirsch E.C., Nunez M.T. Effect of mitochondrial complex I inhibition on Fe-S cluster protein activity. Biochem. Biophys. Res. Commun. 2011, 409:241-246.
87. Mikawa S., Sharp F.R., Kamii H., Kinouchi H., Epstein C.J., Chan P.K. Expression of c-fos and hsp70 mRNA after traumatic brain injury in transgenic mice overexpressing CuZn-superoxide dismutase. Brain Res. Mol. Brain Res. 1995, 33:288-294.
88. Mitrovic B., Ignarro L.J., Vinters H.V., Akers M.A., Schmid I., Uittenbogaart C., Merrill J.E. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 1995, 65:531-539.
89. Muyderman H., Nilsson M., Sims N.R. Highly selective and prolonged depletion of mitochondrial glutathione in astrocytes markedly increases sensitivity to peroxynitrite. J. Neurosci. 2004, 24:8019-8028.
90. Nagel F., Bahr M., Dietz G.P. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins. Brain Res. Bull. 2009, 79:303-309.
91. Niranjan R., Nath C., Shukla R. The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6. Free Radic. Res. 2010, 44:1304-1316.
92. Norazit A., Meedeniya A.C., Nguyen M.N., Mackay-Sim A. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle. Brain Res. 2010, 1360:119-129.
93. O'Neill L.A., Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 1997, 20:252-258.
94. Ogawa N., Asanuma M., Miyazaki I., Diaz-Corrales F.J., Miyoshi K. L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease. J. Neurol. 2005, 252(Suppl. 4):IV23-IV31.
95. Ouyang Y.B., Xu L.J., Emery J.F., Lee A.S., Giffard R.G. Overexpressing GRP78 influences Ca2+ handling and function of mitochondria in astrocytes after ischemia-like stress. Mitochondrion 2011, 11:279-286.
96. Ouyang Y.B., Xu L.J., Sun Y.J., Giffard R.G. Overexpression of inducible heat shock protein 70 and its mutants in astrocytes is associated with maintenance of mitochondrial physiology during glucose deprivation stress. Cell Stress Chaperones 2006, 11:180-186.
97. Pahara J., Shi H., Chen X., Wang Z. Dimerization drives PDGF receptor endocytosis through a C-terminal hydrophobic motif shared by EGF receptor. Exp. Cell Res. 2010, 316:2237-2250.
98. Pan-Montojo F., Anichtchik O., Dening Y., Knels L., Pursche S., Jung R., Jackson S., Gille G., Spillantini M.G., Reichmann H., Funk R.H. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 2010, 5:e8762.
99. Pang Y., Zheng B., Campbell L.R., Fan L.W., Cai Z., Rhodes P.G. IGF-1 can either protect against or increase LPS-induced damage in the developing rat brain. Pediatr. Res. 2010, 67:579-584.
100. Papadopoulos M.C., Koumenis I.L., Dugan L.L., Giffard R.G. Vulnerability to glucose deprivation injury correlates with glutathione levels in astrocytes. Brain Res. 1997, 748:151-156.
101. Parpura V., Grubisic V., Verkhratsky A. Ca(2+) sources for the exocytotic release of glutamate from astrocytes. Biochim. Biophys. Acta 2011, 1813:984-991.
102. Patel F. Pesticidal suicide: adult fatal rotenone poisoning. J. Forensic Leg Med. 2011, 18:340-342.
103. Patel V.P., Chu C.T. Nuclear transport, oxidative stress, and neurodegeneration. Int. J. Clin. Exp. Pathol. 2011, 4:215-229.
104. Pineda J.A., Aono M., Sheng H., Lynch J., Wellons J.C., Laskowitz D.T., Pearlstein R.D., Bowler R., Crapo J., Warner D.S. Extracellular superoxide dismutase overexpression improves behavioral outcome from closed head injury in the mouse. J. Neurotrauma 2001, 18:625-634.
105. Radad K., Gille G., Rausch W.D. Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture. Toxicol. In Vitro 2008, 22:68-74.
106. Rappold P.M., Cui M., Chesser A.S., Tibbett J., Grima J.C., Duan L., Sen N., Javitch J.A., Tieu K. Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:20766-20771.
107. Rizzardini M., Lupi M., Bernasconi S., Mangolini A., Cantoni L. Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid. J. Neurol. Sci. 2003, 207:51-58.
108. Robb S.J., Connor J.R. Nitric oxide protects astrocytes from oxidative stress. Ann. N. Y. Acad. Sci. 2002, 962:93-102.
109. Rutledge E.M., Mongin A.A., Kimelberg H.K. Intracellular ATP depletion inhibits swelling-induced D-[3H]aspartate release from primary astrocyte cultures. Brain Res. 1999, 842:39-45.
110. Safi R., Gardaneh M., Panahi Y., Maghsoudi N., Zaefizadeh M., Gharib E. Optimized quantities of GDNF overexpressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity. J. Mol. Neurosci. 2011, 46:654-665.
111. Salsman S., Felts N., Pye Q.N., Floyd R.A., Hensley K. Induction of Akt phosphorylation in rat primary astrocytes by H2O2 occurs upstream of phosphatidylinositol 3-kinase: no evidence for oxidative inhibition of PTEN. Arch Biochem. Biophys. 2001, 386:275-280.
112. Samantaray S., Knaryan V.H., Guyton M.K., Matzelle D.D., Ray S.K., Banik N.L. The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 2007, 146:741-755.
113. Sanchez-Reus M.I., Peinado I.I., Molina-Jimenez M.F., Benedi J. Fraxetin prevents rotenone-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells. Neurosci. Res. 2005, 53:48-56.
114. Sarafian T.A., Montes C., Imura T., Qi J., Coppola G., Geschwind D.H., Sofroniew M.V. Disruption of astrocyte STAT3 signaling decreases mitochondrial function and increases oxidative stress in vitro. PloS One 2010, 5:e9532.
115. Satoh J., Onoue H., Arima K., Yamamura T. The 14-3-3 protein forms a molecular complex with heat shock protein Hsp60 and cellular prion protein. J. Neuropathol. Exp. Neurol. 2005, 64:858-868.
116. Scatena R., Martorana G.E., Bottoni P., Giardina B. Mitochondrial dysfunction by synthetic ligands of peroxisome proliferator activated receptors (PPARs). IUBMB Life 2004, 56:477-482.
117. Schapira A.H. Complex I: inhibitors, inhibition and neurodegeneration. Exp. Neurol. 2010, 224:331-335.
118. Sherer T.B., Betarbet R., Kim J.H., Greenamyre J.T. Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci. Lett. 2003, 341:87-90.
119. Silver I.A., Erecinska M. Energetic demands of the Na+/K+ ATPase in mammalian astrocytes. Glia 1997, 21:35-45.
120. Sims N.R., Nilsson M., Muyderman H. Mitochondrial glutathione: a modulator of brain cell death. J. Bioenerg. Biomembr. 2004, 36:329-333.
121. Slemmer J.E., Shacka J.J., Sweeney M.I., Weber J.T. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr. Med. Chem. 2008, 15:404-414.
122. Slone S.R., Lesort M., Yacoubian T.A. 14-3-3theta protects against neurotoxicity in a cellular Parkinson's disease model through inhibition of the apoptotic factor Bax. PloS One 2011, 6:e21720.
123. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
124. Solenski N.J., diPierro C.G., Trimmer P.A., Kwan A.L., Helm G.A. Ultrastructural changes of neuronal mitochondria after transient and permanent cerebral ischemia. Stroke 2002, 33:816-824.
125. Stenoien D.L., Cummings C.J., Adams H.P., Mancini M.G., Patel K., DeMartino G.N., Marcelli M., Weigel N.L., Mancini M.A. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet. 1999, 8:731-741.
126. Sugaya K., Chou S., Xu S.J., McKinney M. Indicators of glial activation and brain oxidative stress after intraventricular infusion of endotoxin. Brain Res. Mol. Brain Res. 1998, 58:1-9.
127. Sun D., Lye-Barthel M., Masland R.H., Jakobs T.C. Structural remodeling of fibrous astrocytes after axonal injury. J. Neurosci. 2010, 30:14008-14019.
128. Szewczyk A., Wojtczak L. Mitochondria as a pharmacological target. Pharmacol. Rev. 2002, 54:101-127.
129. Tanaka S., Takehashi M., Matoh N., Iida S., Suzuki T., Futaki S., Hamada H., Masliah E., Sugiura Y., Ueda K. Generation of reactive oxygen species and activation of NF-kappaB by non-Abeta component of Alzheimer's disease amyloid. J. Neurochem. 2002, 82:305-315.
130. Tang Z., Arjunan P., Lee C., Li Y., Kumar A., Hou X., Wang B., Wardega P., Zhang F., Dong L., Zhang Y., Zhang S.Z., Ding H., Fariss R.N., Becker K.G., Lennartsson J., Nagai N., Cao Y., Li X. Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. J. Exp. Med. 2010, 207:867-880.
131. Tanner C.M., Kamel F., Ross G.W., Hoppin J.A., Goldman S.M., Korell M., Marras C., Bhudhikanok G.S., Kasten M., Chade A.R., Comyns K., Richards M.B., Meng C., Priestley B., Fernandez H.H., Cambi F., Umbach D.M., Blair A., Sandler D.P., Langston J.W. Rotenone, paraquat, and Parkinson's disease. Environ. Health Perspect. 2011, 119:866-872.
132. Tiwari M., Lopez-Cruzan M., Morgan W.W., Herman B. Loss of caspase-2-dependent apoptosis induces autophagy after mitochondrial oxidative stress in primary cultures of young adult cortical neurons. J. Biol. Chem. 2011, 286:8493-8506.
133. Tseng H.C., Dichter M.A. Platelet-derived growth factor-BB pretreatment attenuates excitotoxic death in cultured hippocampal neurons. Neurobiol. Dis. 2005, 19:77-83.
134. Tuchsen F., Jensen A.A. Agricultural work and the risk of Parkinson's disease in Denmark, 1981-1993. Scand. J. Work Environ. Health 2000, 26:359-362.
135. van Landeghem F.K., Weiss T., Oehmichen M., von Deimling A. Decreased expression of glutamate transporters in astrocytes after human traumatic brain injury. J. Neurotrauma 2006, 23:1518-1528.
136. Verkhratsky A., Rodriguez J.J., Parpura V. Calcium signalling in astroglia. Mol. Cell Endocrinol. 2012, 353:45-56.
137. Voloboueva L.A., Suh S.W., Swanson R.A., Giffard R.G. Inhibition of mitochondrial function in astrocytes: implications for neuroprotection. J. Neurochem. 2007, 102:1383-1394.
138. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6:626-640.
139. Voos W., Martin H., Krimmer T., Pfanner N. Mechanisms of protein translocation into mitochondria. Biochim. Biophys. Acta 1999, 1422:235-254.
140. Wang H.L., Chou A.H., Wu A.S., Chen S.Y., Weng Y.H., Kao Y.C., Yeh T.H., Chu P.J., Lu C.S. PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons. Biochim. Biophys. Acta 2011, 1812:674-684.
141. Wang X., Qin Z.H., Leng Y., Wang Y., Jin X., Chase T.N., Bennett M.C. Prostaglandin A1 inhibits rotenone-induced apoptosis in SH-SY5Y cells. J. Neurochem. 2002, 83:1094-1102.
142. White L.D., Cory-Slechta D.A., Gilbert M.E., Tiffany-Castiglioni E., Zawia N.H., Virgolini M., Rossi-George A., Lasley S.M., Qian Y.C., Basha M.R. New and evolving concepts in the neurotoxicology of lead. Toxicol. Appl. Pharmacol. 2007, 225:1-27.
143. Xu L., Voloboueva L.A., Ouyang Y., Emery J.F., Giffard R.G. Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J. Cereb. Blood Flow Metab. 2009, 29:365-374.
144. Zhang L.H., Zhang X. Roles of GRP78 in physiology and cancer. J. Cell Biochem. 2010, 110:1299-1305.
145. Zhang S., Liang R., Zhou F., Huang X., Ding J.H., Hu G. Reversal of rotenone-induced dysfunction of astrocytic connexin43 by opening mitochondrial ATP-sensitive potassium channels. Cell Mol. Neurobiol. 2010, 31:111-117.
146. Zheng L., Ishii Y., Tokunaga A., Hamashima T., Shen J., Zhao Q.L., Ishizawa S., Fujimori T., Nabeshima Y., Mori H., Kondo T., Sasahara M. Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved. J. Neurosci. Res. 2010, 88:1273-1284.
147. Zhu M., Gu F., Shi J., Hu J., Hu Y., Zhao Z. Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2. Free Radic. Biol. Med. 2008, 45:1493-1499.
148. Zhu X., Yao H., Peng F., Callen S., Buch S. PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium. Toxicol. Appl. Pharmacol. 2009, 240:286-291.